Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Brain and Central Nervous System Tumors|Breast Cancer|Kidney Cancer|Lung Cancer|Lymphoma|Melanoma (Skin)|Ovarian Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: carboxyamidotriazole|DRUG: paclitaxel
Sponsor: National Institutes of Health Clinical Center (CC)
Collaborators: National Cancer Institute (NCI)